Showing results (1361-1370 of 5,347) with videos related to

Sort By:
Pageof 535
Japanese Journal of Clinical Oncology|March 25, 2011
Alcohol drinking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese populationIsao Oze, Keitaro Matsuo, Kenji Wakai, et al.
Japanese Journal of Clinical Oncology|May 29, 2019
The road map of cancer precision medicine with the innovation of advanced cancer detection technology and personalized immunotherapySiew-Kee Low, Yusuke Nakamura
Japanese Journal of Clinical Oncology|May 29, 2019
Post-marketing observational study of everolimus in patients with unresectable or metastatic renal cell carcinoma in JapanHideyuki Akaza, Ryohei Kurihara, Aiko Katsura, et al.
Japanese Journal of Clinical Oncology|May 8, 2019
Sorafenib versus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a systematic review and meta-analysisBo-Wen Zhuang, Wei Li, Xiao-Hua Xie, et al.
Japanese Journal of Clinical Oncology|May 8, 2019
Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapyGo Kaneko, Suguru Shirotake, Koshiro Nishimoto, et al.
Japanese Journal of Clinical Oncology|April 11, 2019
Effects of TACE and preventive antiviral therapy on HBV reactivation and subsequent hepatitis in hepatocellular carcinoma: a meta-analysisSu-Su Zhang, Jin-Xia Liu, Jing Zhu, et al.
Japanese Journal of Clinical Oncology|June 1, 1997
Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study GroupK Tobinai, M Ogura, T Hotta, et al.
Japanese Journal of Clinical Oncology|June 1, 1997
Second-line chemotherapy for relapsed small cell lung cancerN Ebi, K Kubota, Y Nishiwaki, et al.
Japanese Journal of Clinical Oncology|June 6, 1998
Pharmacokinetics of cisplatin in combined cisplatin and 5-fluorouracil therapy: a comparative study of three different schedules of cisplatin administrationK Ikeda, M Terashima, H Kawamura, et al.
Japanese Journal of Clinical Oncology|June 6, 1998
Changes in levels of serum erythropoietin, serum iron and unsaturated iron binding capacity during chemotherapy for lung cancerY Sawabe, Y Takiguchi, K Kikuno, et al.
Pageof 535